Scientists have made a major discovery about ADAR1—a protein that controls RNA-induced immune responses—paving the way for better treatments for autoimmune diseases and cancer immunotherapy. ADAR1 ...
Mill Valley, CA – September 10, 2024 – The SynGAP Research Fund 501(c)(3) announced a collaboration with Unravel Biosciences, Inc., an AI-enabled therapeutics company, to initiate a clinical study ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback